The ACME Laboratories Ltd. (DSE: ACMELAB)

The ACME Laboratories Revenue

The ACME Laboratories had revenue of 8.00B BDT in the quarter ending March 31, 2024, with 21.51% growth. This brings the company's revenue in the last twelve months to 30.81B, up 19.10% year-over-year. In the fiscal year ending June 30, 2023, The ACME Laboratories had annual revenue of 26.95B with 12.95% growth.

• Revenue (ttm): 30.81B
• Revenue Growth: +19.10%
• P/S Ratio: 0.53
• Revenue / Employee: 3.49M
• Employees: 8,816
• Market Cap: 16.44B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2023	26.95B	3.09B	12.95%
Jun 30, 2022	23.86B	3.09B	14.87%
Jun 30, 2021	20.77B	1.77B	9.30%
Jun 30, 2020	19.00B	2.70B	16.53%
Jun 30, 2019	16.31B	1.49B	10.09%